0.05 ML Eylea 40 MG/ML Injection
- RxCUI
- 1232159
- RxNorm name
- 0.05 ML Eylea 40 MG/ML Injection
- Display name
- 0.05 ML Eylea 40 MG/ML Injection
- Full name
- 0.05 ML Eylea 40 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125387 | Eylea | aflibercept | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EYLEA | AFLIBERCEPT | Regeneron Pharmaceuticals, Inc. | f96cfd69-da34-41ee-90a9-610a4655cd1c | 2026-07-07 | Warnings, Adverse reactions | 1232159 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f96cfd69-da34-41ee-90a9-610a4655cd1c | 0.05 ML Eylea 40 MG/ML Injection | SY | 39 | These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA ® (aflibercept) injection, for intravitreal use Initial U.S. Approval: 2011 | 20251218 |
| f96cfd69-da34-41ee-90a9-610a4655cd1c | EYLEA 2 MG in 0.05 ML Injection | PSN | 39 | These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA ® (aflibercept) injection, for intravitreal use Initial U.S. Approval: 2011 | 20251218 |
| f96cfd69-da34-41ee-90a9-610a4655cd1c | Eylea 2 MG per 0.05 ML Intravitreal Injection | SY | 39 | These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA ® (aflibercept) injection, for intravitreal use Initial U.S. Approval: 2011 | 20251218 |
| f96cfd69-da34-41ee-90a9-610a4655cd1c | 0.05 ML aflibercept 40 MG/ML Injection [Eylea] | SBD | 39 | These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA ® (aflibercept) injection, for intravitreal use Initial U.S. Approval: 2011 | 20251218 |